Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Netherlands

Marie Skłodowska-Curie Action · Running

Mac4Me Macrophage Targets for Metastatic Treatment

Coordinator
Erasmus Universitair Medisch Centrum Rotterdam, Netherlands
Runs
1 November 2024 to 31 October 2028
Status
Running
EU funding
€4.1m
Total cost
—
Partners
26 organisations in 13 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101168661

What the project is doing

In the project's own words, from its summary on CORDIS.

Immunotherapies promise to be the major break-through in the treatment of metastatic cancer, but effectiveness is limited to few cancer types. Metastatic neuroblastoma, breast and prostate cancer, affecting approximately 300,000 EU-27 inhabitants of all age groups in 2020, respond not or very poorly to current immunotherapies. To establish more effective immunotherapies, we need to better understand the specific tumour cell-immune host interactions at the metastatic site.

The Mac4Me Doctoral Network adopts an innovative, multidisciplinary and cross-sectional approach, with a unique and dedicated research training programme to equip young researchers with scientific knowledge and transferable skills that are essential for today’s great demand in both academic and non-academic sectors. Mac4Me aims to understand the tumour cell-immune host interactions at the metastatic site. with an in-depth molecular and mechanistic understanding of the immune and matrix changes induced by tumour cells.

We will use innovative animal-free organ-on-chip systems, that recapitulate early metastasis formation of brain, bone and liver. The retrieved knowledge from the preclinical models will be integrated in data from established clinical metastases and AI machine learning algorithms will be applied to identify new immune targets. Mac4Me will align with patients and the general public from the very beginning thereby bringing societal expectations and patient needs into the centre of the project to pave the way for new standards for shared decision making and acceptable health care solutions.

Mac4Me will prepare a next generation of young scientists to start their own career as independent researchers being equipped with scientific knowledge and personal skills and integrating participatory science as a starting point to address the societal demand for more effective treatment solutions for incurable metastatic disease, such as neuroblastoma, breast and prostate cancer.

Topics

Who is involved

OrganisationCityCountryRole
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsCoordinator
The Garvan Institute of Medical Research Charitable InstitutionSydney NswAustraliaAssociatedpartner
Europa UomoAntwerpenBelgiumAssociatedpartner
Universitaet BernBernSwitzerlandAssociatedpartner
Johann Wolfgang Goethe-Universitaet Frankfurt Am MainFrankfurt Am MainGermanyParticipant
Phialogics GmbHFrankfurt am MainGermanyAssociatedpartner
Ruprecht-Karls-Universitaet HeidelbergHeidelbergGermanyParticipant
Technische Universitaet DresdenDresdenGermanyParticipant
Universidad Pompeu FabraBarcelonaSpainParticipant
Faron Pharmaceuticals OyTurkuFinlandAssociatedpartner
Genevia Technologies OyTampereFinlandParticipant
Helsingin YliopistoHelsinkiFinlandParticipant
Tampereen Korkeakoulusaatio SrTampereFinlandAssociatedpartner
Med'inn'pharmaPlaceyFranceAssociatedpartner
Royal College of Surgeons in IrelandDublin 2IrelandParticipant
University College Dublin, National University of Ireland, DublinDublinIrelandAssociatedpartner
Politecnico Di MilanoMilanoItalyAssociatedpartner
React4life SpAGenovaItalyParticipant
Universita' Degli Studi Di Milano-BicoccaMilanoItalyAssociatedpartner
Erasmus Universiteit RotterdamRotterdamNetherlandsParticipant
Technische Universiteit DelftDelftNetherlandsParticipant
Oslo Universitetssykehus HfOsloNorwayParticipant
European Association for Cancer ResearchNottinghamUnited KingdomAssociatedpartner
Peptimatrix LimitedBeestonUnited KingdomAssociatedpartner
The University of NottinghamNottinghamUnited KingdomAssociatedpartner
GRASP - Guiding Researchers & Advocates to Scientific PartnershipsBaltimoreUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI